Aclaris Therapeutics Inc (ACRS)
1.195
0.00 (0.00%)
USD |
NASDAQ |
Apr 26, 14:16
Aclaris Therapeutics Cash from Operations (TTM): -78.32M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -78.32M |
| September 30, 2023 | -90.68M |
| June 30, 2023 | -73.94M |
| March 31, 2023 | -72.95M |
| December 31, 2022 | -67.57M |
| September 30, 2022 | -65.53M |
| June 30, 2022 | -68.32M |
| March 31, 2022 | -60.87M |
| December 31, 2021 | -52.13M |
| September 30, 2021 | -43.92M |
| June 30, 2021 | -45.46M |
| March 31, 2021 | -44.06M |
| December 31, 2020 | -38.63M |
| September 30, 2020 | -50.17M |
| June 30, 2020 | -61.38M |
| March 31, 2020 | -71.93M |
| December 31, 2019 | -96.44M |
| Date | Value |
|---|---|
| September 30, 2019 | -103.30M |
| June 30, 2019 | -109.80M |
| March 31, 2019 | -110.26M |
| December 31, 2018 | -100.81M |
| September 30, 2018 | -91.77M |
| June 30, 2018 | -75.63M |
| March 31, 2018 | -63.88M |
| December 31, 2017 | -54.66M |
| September 30, 2017 | -44.52M |
| June 30, 2017 | -40.72M |
| March 31, 2017 | -40.37M |
| December 31, 2016 | -34.60M |
| September 30, 2016 | -30.67M |
| June 30, 2016 | -31.33M |
| March 31, 2016 | -24.46M |
| December 31, 2015 | -20.37M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-109.80M
Minimum
Jun 2019
-38.63M
Maximum
Dec 2020
-68.18M
Average
-67.57M
Median
Dec 2022
Cash from Operations (TTM) Benchmarks
| Aldeyra Therapeutics Inc | -30.33M |
| Akoya Biosciences Inc | -50.90M |
| MSP Recovery Inc | -40.02M |
| Bullfrog AI Holdings Inc | -6.001M |
| Cadrenal Therapeutics Inc | -3.530M |